Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Diffusion tensor microscopy data (15.6 μm in-plane) of white matter tracts in the human, pig, and rat spinal cord with corresponding tissue histology.
Effectiveness of intramuscular injections of botulinum toxin in the treatment of disabling cerebellar tremor of the hand.
Impaired oligodendroglial turnover is associated with myelin pathology in Focal Cortical Dysplasia and Tuberous Sclerosis Complex.
Scattering the spotlight on microparticles.
Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.
Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology.
Multiple sclerosis: The resolving lesion revealed.
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
Acute Disseminated Encephalomyelitis.
Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the United States.
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS - YES.
Schwann cell differentiation inhibits interferon-gamma induction of expression of major histocompatibility complex class II and intercellular adhesion molecule-1.
Distribution-based estimates of minimum clinically important difference in cognition, arm function and lower body function after slow release-fampridine treatment of patients with multiple sclerosis.
Functional Predictors Of Physical Activity Levels In Patients With Multiple Sclerosis: 2571 Board #94 June 3, 9: 30 AM - 11: 00 AM.
Successful surgical treatment of scoliosis secondary to Guillain-Barré syndrome: Case report.
Distinguishing ischaemic optic neuropathy from optic neuritis by ganglion cell analysis.
Intravascular lymphoma mimicking multiple sclerosis.
A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients.
Consensus definitions for pediatric MS and other demyelinating disorders in childhood.
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients.
The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor.
Comparison of histopathological effects of perineural administration of bupivacaine and bupivacaine-dexmedetomidine in rat sciatic nerve.
Glial Cells and Integrity of the Nervous System.
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
Pages
« first
‹ previous
…
818
819
820
821
822
823
824
825
826
…
next ›
last »